Growth Capital

Syntopix

In July 2005 we provided funding to the University of Leeds life sciences company Syntopix Ltd. Formed in 2003, Syntopix is based on the leading research of husband and wife team Drs Jon Cove and Anne Eady, both microbiologists in the University's Skin Research Centre. Their work focuses on developing novel therapeutics for dermatological diseases, including acne and Staphylococcus aureus infections such as the 'superbug' MRSA. The company's approach is to generate new therapeutic products for target diseases by identifying novel combinations of compounds which together deliver new therapeutic benefits. The company is rapidly developing a pipeline of its own drug candidates, and expects to commence clinical trials of its lead candidates in the next two to three years.